AstraZeneca Hopes to Have COVID-19 Vaccine Ready by Year’s End
To ensure the vaccine has the longest possible shelf-life, company is not producing injectable vials of the vaccine yet
Cognitive Disorders More Common in People Admitted for COVID-19
Genetic variations may put some individuals at higher risk for severe infection
High SARS-CoV-2 Genomic Load Tied to Worse Outcomes
Genomic load independent risk factor for composite outcome of death, intubation, ECMO
Incidence of Cerebrovascular Disease Quantified in COVID-19
1.4 percent of patients with COVID-19 have acute cerebrovascular disease, most often acute ischemic stroke
American College of Chest Physicians, Oct. 18-21
The 86th Annual Meeting of the American College of Chest Physicians The annual meeting of the American College of Chest Physicians was held...
Trial of Antibody Drug for COVID-19 Stopped for Lack of Effectiveness
Eli Lilly says government is continuing a separate study testing the antibody drug in mild to moderately ill patients
COVID-19 Patients More Often Have Vitamin D Deficiency
COVID-19 patients with vitamin D deficiency have increased serum ferritin, troponin levels
Factors ID’d for Strong Antibody Response in COVID-19
Increased antibody responses associated with male sex, older age, hospitalizations for COVID-19
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
U.S. Food and Drug Administration authorized the restart after reviewing all safety data
Hospitals Straining Under Weight of Surging COVID-19 Case Counts
More than 41,000 COVID-19 patients hospitalized across the country, a 40 percent rise in the past month
